Clinical Trials Logo

Non-diabetic Neuropathy clinical trials

View clinical trials related to Non-diabetic Neuropathy.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01132326 Completed - Clinical trials for Neurogenic Orthostatic Hypotension

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)

NOH304
Start date: January 2009
Phase: Phase 3
Study type: Interventional

Symptomatic NOH in patients with primary autonomic failure is thought to be a consequence of norepinephrine depletion leading to a diminished capacity to effect an appropriate cardiovascular response to an orthostatic challenge resulting in symptomatic cerebral-hypoperfusion. Droxidopa augments norepinephrine levels which should lead to improved cerebral perfusion following orthostatic challenge thereby reducing the symptoms of NOH. The present study will evaluate the long-term safety of droxidopa.

NCT ID: NCT00782340 Completed - Clinical trials for Dopamine Beta Hydroxylase Deficiency

A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa

NOH301
Start date: September 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to see whether droxidopa is effective in treating symptoms of neurogenic orthostatic hypotension in patients with Primary Autonomic Failure (Pure Autonomic Failure, Multiple System Atrophy, Parkinson's Disease), Non-diabetic neuropathy, or Beta Hydroxylase deficiency.

NCT ID: NCT00633880 Completed - Clinical trials for Dopamine Beta Hydroxylase Deficiency

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

NOH302
Start date: January 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to see whether droxidopa is effective in treating symptoms of neurogenic orthostatic hypotension in patients with Primary Autonomic Failure (Pure Autonomic Failure, Multiple System Atrophy, Parkinson's Disease), Non-diabetic neuropathy, or Beta Hydroxylase deficiency.